We are live on ! Find out more
GRTX

Galera Therapeutics, Inc. Common Stock
GRTX

Delisted

GRTX was delisted on the 3rd of June, 2024.

Back to rankings

1 hedge funds and large institutions have $7.13K invested in Galera Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% less funds holding

Funds holding: 36 → 1 (-35)

99% less capital invested

Capital invested by funds: $1.37M → $7.13K (-$1.36M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 35

Holders
1
Holders Change
-35
Holders Change %
-97.22%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
35
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$4.86K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$509K
2
Blackstone Inc
Blackstone Inc
New York
-$235K
3
Aberdeen Group
Aberdeen Group
United Kingdom
-$126K
4
NFGH
Nan Fung Group Holdings
Hong Kong
-$85.9K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$62.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
XT
1
XTX Topco
Cayman Islands
$7.13K +$4.86K +26,867 +106%
GCP
2
GSA Capital Partners
United Kingdom
– -$509K -3,632,627 Closed
Blackstone Inc
3
Blackstone Inc
New York
– -$235K -1,678,984 Closed
Aberdeen Group
4
Aberdeen Group
United Kingdom
– -$126K -898,374 Closed
NFGH
5
Nan Fung Group Holdings
Hong Kong
– -$85.9K -613,223 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$62.8K -448,330 Closed
Geode Capital Management
7
Geode Capital Management
Massachusetts
– -$61.7K -440,349 Closed
BlackRock
8
BlackRock
New York
– -$50K -357,192 Closed
AI
9
Atom Investors
Texas
– -$49.9K -356,204 Closed
UBS Group
10
UBS Group
Switzerland
– -$41.1K -293,502 Closed
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
– -$40.1K -286,180 Closed
STA
12
Summit Trail Advisors
New York
– -$20.7K -147,658 Closed
State Street
13
State Street
Massachusetts
– -$14.9K -106,564 Closed
Millennium Management
14
Millennium Management
New York
– -$10.7K -76,630 Closed
MF
15
Manchester Financial
California
– -$10.1K -72,000 Closed
Northern Trust
16
Northern Trust
Illinois
– -$9.66K -69,029 Closed
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
– -$5K -35,403 Closed
Group One Trading
18
Group One Trading
Illinois
– -$4.58K -32,720 Closed
KAS
19
Kestra Advisory Services
Texas
– -$4.51K -32,250 Closed
GLA
20
Good Life Advisors
Pennsylvania
– -$4.38K -31,250 Closed
LFAS
21
Level Four Advisory Services
Texas
– -$3.85K -26,441 Closed
Bank of New York Mellon
22
Bank of New York Mellon
New York
– -$3.08K -22,020 Closed
Vontobel Holding
23
Vontobel Holding
Switzerland
– -$2.76K -20,000 Closed
LPL Financial
24
LPL Financial
California
– -$2.53K -18,102 Closed
HF
25
HRT Financial
New York
– -$2K -15,782 Closed
1
2

GRTX Hedge Fund Activity: Q2 2024 in Review

1 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q2 2024, worth a combined $7.13K — down 99% from $1.37M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of GRTX and 0 opened new positions — a net loss of 35 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was XTX Topco, adding an estimated $4.86K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $509K sold.

  • 1 institutional investor held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q2 2024, down from 36 in Q1 2024.
  • Funds reported $7.13K of Galera Therapeutics, Inc. Common Stock stock for Q2 2024, down 99% quarter-over-quarter.
  • 0 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q2 2024 and 35 closed out, a net change of -35 holders.
  • The largest Galera Therapeutics, Inc. Common Stock buyer in Q2 2024 was XTX Topco, an estimated $4.86K added.
  • The largest Galera Therapeutics, Inc. Common Stock seller in Q2 2024 was GSA Capital Partners, an estimated $509K sold.

Based on aggregated 13F filings for Q2 2024.